(NASDAQ: OPK) Opko Health's forecast annual revenue growth rate of 1.33% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.27%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.65%.
Opko Health's revenue in 2025 is $664,029,000.On average, 5 Wall Street analysts forecast OPK's revenue for 2025 to be $503,820,280,728, with the lowest OPK revenue forecast at $463,807,278,354, and the highest OPK revenue forecast at $540,327,938,346. On average, 5 Wall Street analysts forecast OPK's revenue for 2026 to be $505,733,297,228, with the lowest OPK revenue forecast at $467,696,813,976, and the highest OPK revenue forecast at $610,736,470,932.
In 2027, OPK is forecast to generate $561,902,954,306 in revenue, with the lowest revenue forecast at $505,242,739,470 and the highest revenue forecast at $663,999,295,470.